1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gadopentetic Acid Dimeglumine Salt Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gadopentetic Acid Dimeglumine Salt Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gadopentetic Acid Dimeglumine Salt Injection by Country/Region, 2018, 2022 & 2029
2.2 Gadopentetic Acid Dimeglumine Salt Injection Segment by Type
2.2.1 12ml:5.63g
2.2.2 15ml:7.04g
2.3 Gadopentetic Acid Dimeglumine Salt Injection Sales by Type
2.3.1 Global Gadopentetic Acid Dimeglumine Salt Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Gadopentetic Acid Dimeglumine Salt Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gadopentetic Acid Dimeglumine Salt Injection Sale Price by Type (2018-2023)
2.4 Gadopentetic Acid Dimeglumine Salt Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Gadopentetic Acid Dimeglumine Salt Injection Sales by Application
2.5.1 Global Gadopentetic Acid Dimeglumine Salt Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Gadopentetic Acid Dimeglumine Salt Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gadopentetic Acid Dimeglumine Salt Injection Sale Price by Application (2018-2023)
3 Global Gadopentetic Acid Dimeglumine Salt Injection by Company
3.1 Global Gadopentetic Acid Dimeglumine Salt Injection Breakdown Data by Company
3.1.1 Global Gadopentetic Acid Dimeglumine Salt Injection Annual Sales by Company (2018-2023)
3.1.2 Global Gadopentetic Acid Dimeglumine Salt Injection Sales Market Share by Company (2018-2023)
3.2 Global Gadopentetic Acid Dimeglumine Salt Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Gadopentetic Acid Dimeglumine Salt Injection Revenue by Company (2018-2023)
3.2.2 Global Gadopentetic Acid Dimeglumine Salt Injection Revenue Market Share by Company (2018-2023)
3.3 Global Gadopentetic Acid Dimeglumine Salt Injection Sale Price by Company
3.4 Key Manufacturers Gadopentetic Acid Dimeglumine Salt Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gadopentetic Acid Dimeglumine Salt Injection Product Location Distribution
3.4.2 Players Gadopentetic Acid Dimeglumine Salt Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gadopentetic Acid Dimeglumine Salt Injection by Geographic Region
4.1 World Historic Gadopentetic Acid Dimeglumine Salt Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Gadopentetic Acid Dimeglumine Salt Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gadopentetic Acid Dimeglumine Salt Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gadopentetic Acid Dimeglumine Salt Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Gadopentetic Acid Dimeglumine Salt Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gadopentetic Acid Dimeglumine Salt Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gadopentetic Acid Dimeglumine Salt Injection Sales Growth
4.4 APAC Gadopentetic Acid Dimeglumine Salt Injection Sales Growth
4.5 Europe Gadopentetic Acid Dimeglumine Salt Injection Sales Growth
4.6 Middle East & Africa Gadopentetic Acid Dimeglumine Salt Injection Sales Growth
5 Americas
5.1 Americas Gadopentetic Acid Dimeglumine Salt Injection Sales by Country
5.1.1 Americas Gadopentetic Acid Dimeglumine Salt Injection Sales by Country (2018-2023)
5.1.2 Americas Gadopentetic Acid Dimeglumine Salt Injection Revenue by Country (2018-2023)
5.2 Americas Gadopentetic Acid Dimeglumine Salt Injection Sales by Type
5.3 Americas Gadopentetic Acid Dimeglumine Salt Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gadopentetic Acid Dimeglumine Salt Injection Sales by Region
6.1.1 APAC Gadopentetic Acid Dimeglumine Salt Injection Sales by Region (2018-2023)
6.1.2 APAC Gadopentetic Acid Dimeglumine Salt Injection Revenue by Region (2018-2023)
6.2 APAC Gadopentetic Acid Dimeglumine Salt Injection Sales by Type
6.3 APAC Gadopentetic Acid Dimeglumine Salt Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gadopentetic Acid Dimeglumine Salt Injection by Country
7.1.1 Europe Gadopentetic Acid Dimeglumine Salt Injection Sales by Country (2018-2023)
7.1.2 Europe Gadopentetic Acid Dimeglumine Salt Injection Revenue by Country (2018-2023)
7.2 Europe Gadopentetic Acid Dimeglumine Salt Injection Sales by Type
7.3 Europe Gadopentetic Acid Dimeglumine Salt Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gadopentetic Acid Dimeglumine Salt Injection by Country
8.1.1 Middle East & Africa Gadopentetic Acid Dimeglumine Salt Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gadopentetic Acid Dimeglumine Salt Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Gadopentetic Acid Dimeglumine Salt Injection Sales by Type
8.3 Middle East & Africa Gadopentetic Acid Dimeglumine Salt Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gadopentetic Acid Dimeglumine Salt Injection
10.3 Manufacturing Process Analysis of Gadopentetic Acid Dimeglumine Salt Injection
10.4 Industry Chain Structure of Gadopentetic Acid Dimeglumine Salt Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gadopentetic Acid Dimeglumine Salt Injection Distributors
11.3 Gadopentetic Acid Dimeglumine Salt Injection Customer
12 World Forecast Review for Gadopentetic Acid Dimeglumine Salt Injection by Geographic Region
12.1 Global Gadopentetic Acid Dimeglumine Salt Injection Market Size Forecast by Region
12.1.1 Global Gadopentetic Acid Dimeglumine Salt Injection Forecast by Region (2024-2029)
12.1.2 Global Gadopentetic Acid Dimeglumine Salt Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gadopentetic Acid Dimeglumine Salt Injection Forecast by Type
12.7 Global Gadopentetic Acid Dimeglumine Salt Injection Forecast by Application
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Gadopentetic Acid Dimeglumine Salt Injection Product Portfolios and Specifications
13.1.3 Bayer Gadopentetic Acid Dimeglumine Salt Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Gadopentetic Acid Dimeglumine Salt Injection Product Portfolios and Specifications
13.2.3 GE Healthcare Gadopentetic Acid Dimeglumine Salt Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Bracco
13.3.1 Bracco Company Information
13.3.2 Bracco Gadopentetic Acid Dimeglumine Salt Injection Product Portfolios and Specifications
13.3.3 Bracco Gadopentetic Acid Dimeglumine Salt Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bracco Main Business Overview
13.3.5 Bracco Latest Developments
13.4 Beijing Beilu Pharmaceutical Co., Ltd.
13.4.1 Beijing Beilu Pharmaceutical Co., Ltd. Company Information
13.4.2 Beijing Beilu Pharmaceutical Co., Ltd. Gadopentetic Acid Dimeglumine Salt Injection Product Portfolios and Specifications
13.4.3 Beijing Beilu Pharmaceutical Co., Ltd. Gadopentetic Acid Dimeglumine Salt Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beijing Beilu Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Beijing Beilu Pharmaceutical Co., Ltd. Latest Developments
13.5 Consun Pharmaceutical Group Limited
13.5.1 Consun Pharmaceutical Group Limited Company Information
13.5.2 Consun Pharmaceutical Group Limited Gadopentetic Acid Dimeglumine Salt Injection Product Portfolios and Specifications
13.5.3 Consun Pharmaceutical Group Limited Gadopentetic Acid Dimeglumine Salt Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Consun Pharmaceutical Group Limited Main Business Overview
13.5.5 Consun Pharmaceutical Group Limited Latest Developments
13.6 Shanghai Xudong HaipuPharmaceutical Co., Ltd.
13.6.1 Shanghai Xudong HaipuPharmaceutical Co., Ltd. Company Information
13.6.2 Shanghai Xudong HaipuPharmaceutical Co., Ltd. Gadopentetic Acid Dimeglumine Salt Injection Product Portfolios and Specifications
13.6.3 Shanghai Xudong HaipuPharmaceutical Co., Ltd. Gadopentetic Acid Dimeglumine Salt Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shanghai Xudong HaipuPharmaceutical Co., Ltd. Main Business Overview
13.6.5 Shanghai Xudong HaipuPharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion
※参考情報 ガドペンテチン酸ジメグルミン塩注射は、医療分野において重要な役割を果たす造影剤の一種です。特にMRI(磁気共鳴画像法)検査において使用され、腫瘍や血管病変、神経系の病変などの診断においてその効果を発揮します。この薬剤は、診断能を向上させるために特別に設計されており、ほかの造影剤と比較しても特有の特徴を持っています。 ガドペンテチン酸ジメグルミン塩は、ガドリニウムという金属を含む化合物で、その特性を利用して画像のコントラストを向上させることができます。ガドリニウムは強い磁気特性を持つため、MRIスキャン時に周囲の組織と異なる信号を発生させ、病変の検出を容易にします。この薬剤は、体内での分布が速く、また短時間で排泄されるため、使用後の副作用が比較的少ないという特徴があります。 ガドペンテチン酸ジメグルミン塩は、主に悪性腫瘍の評価や、脳血管障害、神経変性疾患などにおいて使用されます。例えば、腫瘍の評価においては、造影剤を使用することで腫瘍の大きさや周囲組織との関係を詳細に確認することが可能となり、治療計画の立案に重要な情報を提供します。また、脳血管障害の場合、血流の状態や血管形態を明確にすることで、早期診断や適切な治療介入が可能となります。 ガドペンテチン酸ジメグルミン塩注射は、その使用にあたって一定の注意が必要です。特に、腎機能が低下している患者に対しては、使用を避けるべきであるとされています。これは、ガドリニウムが体内での排泄が遅れ、腎不全やガドリニウム蓄積症候群(NSF)を引き起こす可能性があるためです。したがって、使用前には患者の腎機能をチェックし、リスクを適切に評価することが重要です。 この薬剤がもたらす画像診断の精度向上は、医療現場において非常に大きな意義を持ちます。早期診断が可能になることで、治療の選択肢が広がるだけでなく、患者の予後を改善する可能性も高まります。また、近年では、より低い投与量で同等の効果を得られる新しい製剤の開発も進められており、今後の進展が期待されます。 ガドペンテチン酸ジメグルミン塩に関連する技術としては、MRIの技術自体の進化が重要です。より高解像度の画像を得るための技術革新や、造影剤の効果を最大限に引き出すための技術が開発され続けています。また、AI(人工知能)を利用した画像解析技術が進化することで、より正確な診断や病変の定量評価が可能になることが期待されています。 さらに、ガドペンテチン酸ジメグルミン塩は、臨床試験や研究においても使用されており、新しい治療法の開発や病態の研究に貢献しています。具体的には、新しい抗がん剤や治療法の有効性を評価するための臨床試験において、腫瘍の特性を詳細に把握し、治療効果を図るために使用されます。このように、ガドペンテチン酸ジメグルミン塩は、単なる診断薬にとどまらず、研究や新たな治療の開発にも寄与しているのです。 総じて、ガドペンテチン酸ジメグルミン塩注射は、現代の医療においてなくてはならない存在となっており、様々な病態に対する診断能を高める重要なツールとして位置付けられています。その性質を理解し、適切な使用を行うことで、より多くの患者に対して質の高い医療を提供することが可能となります。今後も、この領域における研究と技術の進展に期待が寄せられています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/